We are a global think tank that promotes the power of data to tackle antimicrobial resistance.

We bring together diverse expertise to identify evidence gaps, describe solutions and advocate for research and policy change.

Map of health by Odra Noel

Why it’s important

Antibiotics are the cornerstone of modern medicine and have made procedures such as caesarean delivery and surgeries safe for millions. Drug-resistant bacteria threaten to roll back the clock on decades of progress if we don’t take work to address antimicrobial resistance. 

Without action now, the number of people dying each year from drug-resistant infections could rise from 700,000 to 10 million by 2050.

What we do

We bring together diverse expertise to identify evidence gaps, describe solutions and advocate for research and policy change.

Working groups

Our working groups, comprised of SEDRIC Board members and the wider membership, investigate identified gaps in AMR surveillance.

More about working groups

Publications

We share the latest findings from our working groups and other research initiatives. All journal publications written by SEDRIC are open access and available to download.

Browse publications

Member networking

SEDRIC connects AMR surveillance and epidemiology professionals around the world, and organises events to help our members network.

Search for members View events

Become a member

Are you working in AMR surveillance and epidemiology? Join SEDRIC today to start communicating and collaborating with our community of experts.

News

Recent tweets

#COVID19 may increase the spread of #AMR due to increasing rates of antimicrobial prescribing and potential breakdowns in well-established stewardship programmes.

Find out more about COVID19 & the potential long-term impact on #antimicrobialresistance πŸ‘‡ https://t.co/wuZ8jkpavg

We will soon be launching an interactive global map for the SEDRIC website which allow members to upload AMR #surveillance and #epidemiology projects 🌏🌍🌎

It will provide a global and national overview of AMR surveillance projects and show where gaps exist πŸ—ΊοΈ

Putting actionable data into the hands of decision makers to tackle drug-resistant infections is a key aim of the Surveillance Partnership to Improve Data for Action on Antimicrobial Resistance (SPIDAAR) πŸ’ŠπŸ¦ πŸ—£οΈ

You can read more about SPIDAAR here – https://t.co/gYYtxgvL4z